Department of Surgery, Davis Heart and Lung Research Institute, Biomedical Sciences Graduate Program, Biophysics Graduate Program, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Department of Surgery, Davis Heart and Lung Research Institute, Biomedical Sciences Graduate Program, Biophysics Graduate Program, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Mol Ther. 2020 Jul 8;28(7):1696-1705. doi: 10.1016/j.ymthe.2020.04.009. Epub 2020 Apr 16.
Adenine base editor (ABE) is a new generation of genome-editing technology through fusion of Cas9 nickase with an evolved E. coli TadA (TadA∗) and holds great promise as novel genome-editing therapeutics for treating genetic disorders. ABEs can directly convert A-T to G-C in specific genomic DNA targets without introducing double-strand breaks (DSBs). We recently showed that computer program-assisted analysis of Sanger sequencing traces can be used as a low-cost and rapid alternative of deep sequencing to assess base-editing outcomes. Here we developed a rapid fluorescence-based reporter assay (Base Editing ON [BEON]) to quantify ABE efficiency. The assay relies on the restoration of the downstream green fluorescent protein (GFP) in ABE-mediated editing of a stop codon located within the guide RNA (gRNA). We showed that this assay can be used to screen for effective ABE variants, characterize the protospacer adjacent motif (PAM) requirement of a novel NNG-targeting ABE based on ScCas9, and enrich for edited cells. Finally, we demonstrated that the reporter assay allowed us to assess the feasibility of ABE editing to correct point mutations associated with dysferlinopathy. Taken together, the BEON assay would facilitate and simplify the studies with ABEs.
腺嘌呤碱基编辑器(ABE)是一种新一代的基因组编辑技术,通过将 Cas9 核酸酶与进化的大肠杆菌 TadA(TadA∗)融合,有望成为治疗遗传疾病的新型基因组编辑治疗方法。ABE 可以在特定的基因组 DNA 靶标中直接将 A-T 转换为 G-C,而不会引入双链断裂(DSBs)。我们最近表明,基于计算机程序的 Sanger 测序轨迹分析可以作为一种低成本、快速的替代方法,用于评估碱基编辑结果。在这里,我们开发了一种快速荧光报告基因检测法(Base Editing ON [BEON])来定量 ABE 的效率。该检测法依赖于在向导 RNA(gRNA)内的终止密码子处进行 ABE 介导的编辑后,下游绿色荧光蛋白(GFP)的恢复。我们表明,该检测法可用于筛选有效的 ABE 变体,基于 ScCas9 来表征新型 NNG 靶向 ABE 的邻近基序(PAM)要求,并富集编辑后的细胞。最后,我们证明该报告基因检测法可用于评估 ABE 编辑纠正与 dysferlinopathy 相关的点突变的可行性。总之,BEON 检测法将简化 ABE 的研究。